Stefanie Hammer

Person

Berlin, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
- Patent number 11,660,351
- Issue date May 30, 2023
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) having enzymatically cleavable groups
- Patent number 11,478,554
- Issue date Oct 25, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody drug conjugates (ADCs) having KSP inhibitors
- Patent number 11,433,140
- Issue date Sep 6, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...
- Patent number 11,071,788
- Issue date Jul 27, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20230338559
- Publication date Oct 26, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PR...
- Publication number 20230072421
- Publication date Mar 9, 2023
- BAYER AS
- Niels BÖHNKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20220362392
- Publication date Nov 17, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF PD-1/PD-L1 INHIBITORS AND TARGETED THORIUM CONJUGATES
- Publication number 20220125960
- Publication date Apr 28, 2022
- Bayer Aktiengesellschaft
- Urs Beat HAGEMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF AR ANTAGONISTS AND TARGETED THORIUM CONJUGATES
- Publication number 20220118123
- Publication date Apr 21, 2022
- Bayer Aktiengesellschaft
- Stefanie HAMMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20220016258
- Publication date Jan 20, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDER/ACTIVE AGENT CONJUGATES DIRECTED AGAINST CXCR5, HAVING ENZYM...
- Publication number 20210275686
- Publication date Sep 9, 2021
- Bayer Aktiengesellschaft
- Sarah Anna Liesa JOHANNES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF PI3K-INHIBITORS AND TARGETED THORIUM CONJUGATES
- Publication number 20210187134
- Publication date Jun 24, 2021
- BAYER AS
- Urs HAGEMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS
- Publication number 20200360531
- Publication date Nov 19, 2020
- Bayer Aktiengesellschaft
- Niels BÖHNKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20200138970
- Publication date May 7, 2020
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20190365916
- Publication date Dec 5, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20190328897
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RADIO-PHARMACEUTICAL COMPLEXES
- Publication number 20190298865
- Publication date Oct 3, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Alan CUTHBERTSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TWEAKR ANTIBODIES AND USES THEREOF
- Publication number 20160237160
- Publication date Aug 18, 2016
- BAYER PHARMA AKTIENGESELLSCHAFT
- Christian VOTSMEIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOF
- Publication number 20150023989
- Publication date Jan 22, 2015
- Seattle Genetics, Inc.
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-FGFR2 Antibodies and Uses Thereof
- Publication number 20140322220
- Publication date Oct 30, 2014
- Bayer Intellectual Property GmbH
- Axel Harrenga
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS, KITS, AND COMPOUNDS FOR DETERMINING RESPONSIVENESS TO TREA...
- Publication number 20090076098
- Publication date Mar 19, 2009
- Jens Hoffmann
- G01 - MEASURING TESTING

Stefanie Hammer

Person

Patents Grantslast 30 patents

Antibody drug conjugates (ADCs) having enzymatically cleavable groups

Antibody drug conjugates (ADCS) having enzymatically cleavable groups

Specific antibody drug conjugates (ADCs) having KSP inhibitors

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...

Patents Applicationslast 30 patents

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PR...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

COMBINATION OF PD-1/PD-L1 INHIBITORS AND TARGETED THORIUM CONJUGATES

COMBINATION OF AR ANTAGONISTS AND TARGETED THORIUM CONJUGATES

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

BINDER/ACTIVE AGENT CONJUGATES DIRECTED AGAINST CXCR5, HAVING ENZYM...

COMBINATION OF PI3K-INHIBITORS AND TARGETED THORIUM CONJUGATES

ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

RADIO-PHARMACEUTICAL COMPLEXES

ANTI-TWEAKR ANTIBODIES AND USES THEREOF

NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOF

Anti-FGFR2 Antibodies and Uses Thereof

METHODS, KITS, AND COMPOUNDS FOR DETERMINING RESPONSIVENESS TO TREA...